Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, dated April 23, 2025, reports a transaction in own shares. Haleon is a global leader in consumer health with a portfolio spanning Oral Health, Pain Relief, Respiratory Health, Digestive Health, and Vitamins, Minerals, and Supplements (VMS). The filing details share repurchases executed under a buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. It focuses exclusively on share capital movements.
- Shares Purchased: 846,782 ordinary shares
- Purchase Date: April 22, 2025
- Highest Price Paid: 387.20 pence per share
- Lowest Price Paid: 381.00 pence per share
- Volume Weighted Average Price: 384.04 pence per share
- Registered Share Capital: 9,026,151,961 ordinary shares of £0.01 each
- Treasury Shares Held: 4,080,205
- Voting Shares Outstanding: 9,022,071,756
Material Changes
The primary material change is the reduction of outstanding voting shares following the cancellation of 846,782 shares purchased on April 22, 2025. The number of shares held as treasury shares remains at 4,080,205 post-settlement.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future performance. It includes a standard disclaimer stating the announcement does not constitute an offer or solicitation of an offer for securities. A full breakdown of individual trades is referenced as available via the London Stock Exchange and the company website.
Key Facts for Investor Verification
- Verify the total number of voting shares (9,022,071,756) for compliance with FCA Disclosure Guidance and Transparency Rules.
- Confirm the remaining authorization under the share buyback programme announced on March 28, 2025.
- Review the individual trade breakdown at the provided RNS link for detailed execution data.